Twist Bioscience
TWSTNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$7.952 B
$119.94 -15.88%
Close of 6 Nov 2026
As of 6 Nov 2026, Twist Bioscience (TWST) has a market capitalization of $7.95B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$77.7M
Loss-making
Shares outstanding
62,707,424
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #16Krystal BiotechKRYS$8.92B
- #17ImmunityBioIBRX$8.48B
- #18Twist BioscienceTWST$7.95B
- #19ImmunovantIMVT$5.87B
- #20CG OncologyCGON$5.74B
What if Twist Bioscience were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Twist Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.